Article Details
Retrieved on: 2025-08-23 02:47:57
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In 2018, GlaxoSmithKline reported that GSK933776, a monoclonal antibody designed to bind to beta-amyloid, had no effect on the growth of GA lesions in ...
Article found on: www.drugdiscoverynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here